Iovance Biotherapeutics, Inc. Common Stock (IOVA)
Iovance Biotherapeutics (IOVA) sees significant social media buzz around clinical trial data and partnerships, despite recent stock price lows. Analysts and insiders express confidence, fueling optimism for future growth.
About Iovance Biotherapeutics, Inc. Common Stock
Iovance Biotherapeutics, Inc. is a biotechnology company focused on cancer immunotherapy.
Iovance Biotherapeutics, Inc. Common Stock uses the ticker $IOVA for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Iovance Biotherapeutics, Inc. Common Stock (IOVA) social dominance hit [------] which is 233% higher than it's daily average.
- Iovance Biotherapeutics, Inc. Common Stock (IOVA) social dominance is up 490.82% from the previous week.
- Iovance Biotherapeutics, Inc. Common Stock (IOVA) engagements is up 14.81% from the previous week.
Price: $2.60
Price 24-Hour Time-Series Raw Data
The stock is trading near its 52-week low, but increasing social media sentiment and anticipation of clinical trial data suggest a potential short squeeze is building, driven by undervaluation. Recent posts highlight positive developments and strong patient outcomes, which could be contributing to the upward pressure.
7-Day: -1.1% 30-Day: 8.9%
1-Year High: $5.80 on 2025-02-21
1-Year Low: $1.70 on 2025-05-16
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Iovance Biotherapeutics, Inc. Common Stock (IOVA) is currently AltRank #410 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +154
[--] Months: [---] +219
[--] Year: [---] +424
1-Year High: [-----] on 2025-07-12
1-Year Low: [--] on 2025-08-03
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] +18
[--] Year: [--] [---]
1-Year High: [--] on 2025-12-17
1-Year Low: [--] on 2025-09-12
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +15%
[--] Month: [-------] +10%
[--] Months: [---------] -27%
[--] Year: [----------] -27%
1-Year High: [-------] on 2025-07-23
1-Year Low: [-----] on 2025-12-14
Engagements by network (24h): TikTok: [--] Reddit: [--] News: [--] X: [------] YouTube: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -19%
[--] Month: [-----] +33%
[--] Months: [-----] -3.40%
[--] Year: [------] +5.70%
1-Year High: [---] on 2025-07-31
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] X: [---] YouTube: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Iovance Biotherapeutics, Inc. Common Stock (IOVA) in the last [--] hours which is up 79% from [--] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -21%
[--] Month: [---] +3.90%
[--] Months: [-----] -23%
[--] Year: [-----] +109%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-14
The most influential creators that mention Iovance Biotherapeutics, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @yss4318 | [--] | [-----] | [--] | [-----] |
| @JanvDes | [--] | [--] | [--] | [---] |
| @TradingXtrades | [--] | [-----] | [--] | [---] |
| @OldGoldHawkeye | [--] | [---] | [--] | [---] |
| @Tautilas | [--] | [-----] | [--] | [---] |
| @TradeLand_USA | [--] | [--] | [--] | [---] |
| @OptionsAlertsAi | [--] | [---] | [--] | [---] |
| @jy201506 | [--] | [---] | [--] | [---] |
| @kainvests | [--] | [---] | [--] | [---] |
Sentiment: 61%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 61%
Daily Average: 75%
[--] Week: 60% -27%
[--] Month: 71% +7%
[--] Months: 71% -24%
[--] Year: 71% -7%
1-Year High: 96% on 2025-08-21
1-Year Low: 47% on 2025-12-10
Most Supportive Themes:
- Clinical Trial Progress and Data Releases: (45%) Anticipation for upcoming clinical trial data, particularly for NSCLC and IOV 4001, is driving optimism.
- Analyst Ratings and Insider Confidence: (30%) HC Wainwright's 'buy' rating and increased insider stake signal positive sentiment.
- Partnership with McKesson: (25%) The collaboration with McKesson's InspiroGene for Amtagvi is viewed as a significant positive development.
Most Critical Themes:
- Stock Price Performance: (70%) Concerns persist regarding the stock's performance near a 52-week low and negative price trends across various timeframes.
- Market Dominance and Competition: (30%) The company faces challenges in market dominance and competition within the biotech sector.
Social Dominance: 0.027%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.027%
Daily Average: 0.029%
[--] Week: 0.058% +0.048%
[--] Month: 0.097% +0.071%
[--] Months: 0.097% +0.022%
[--] Year: 0.097% +0.064%
1-Year High: 0.097% on 2026-02-17
1-Year Low: 0.0062% on 2025-09-14
Market Dominance: 0.00116%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00116%
Daily Average: 0%
1-Year High: 0.041% on 2025-03-31
1-Year Low: 0.00074% on 2025-07-07
Market Cap: $1,021,041,316
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,021,041,316
Daily Average: $924,993,115
[--] Week: $1,021,041,316 -1%
[--] Month: $1,020,207,683 +8.90%
[--] Months: $1,020,207,683 +11%
[--] Year: $1,020,207,683 -40%
1-Year High: $1,895,127,291 on 2025-02-21
1-Year Low: $554,331,082 on 2025-05-16
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing